Elsevier

Academic Radiology

Volume 16, Issue 7, July 2009, Pages 842-851
Academic Radiology

Original investigation
Prediction of Malignant Breast Lesions from MRI Features: A Comparison of Artificial Neural Network and Logistic Regression Techniques

https://doi.org/10.1016/j.acra.2009.01.029Get rights and content

Rationale and Objectives

Dynamic contrast-enhanced magnetic resonance imaging is a clinical imaging modality for the detection and diagnosis of breast lesions. Analytic methods were compared for diagnostic feature selection and the performance of lesion classification to differentiate between malignant and benign lesions in patients.

Materials and Methods

The study included 43 malignant and 28 benign histologically proved lesions. Eight morphologic parameters, 10 gray-level co-occurrence matrix texture features, and 14 Laws texture features were obtained using automated lesion segmentation and quantitative feature extraction. Artificial neural network (ANN) and logistic regression analysis were compared for the selection of the best predictors of malignant lesions among the normalized features.

Results

Using ANN, the final four selected features were compactness, energy, homogeneity, and Law_LS, with an area under the receiver-operating characteristic curve (AUC) of 0.82 and accuracy of 0.76. The diagnostic performance of these four features computed on the basis of logistic regression yielded an AUC of 0.80 (95% confidence interval [CI], 0.688–0.905), similar to that of ANN. The analysis also showed that the odds of a malignant lesion decreased by 48% (95% CI, 25%–92%) for every increase of 1 standard deviation in the Law_LS feature, adjusted for differences in compactness, energy, and homogeneity. Using logistic regression with z-score transformation, a model composed of compactness, normalized radial length entropy, and gray-level sum average was selected, and it had the highest overall accuracy, 0.75, among all models, with an AUC of 0.77 (95% CI, 0.660–0.880). When logistic modeling of transformations using the Box-Cox method was performed, the most parsimonious model with predictors compactness and Law_LS had an AUC of 0.79 (95% CI, 0.672–0.898).

Conclusion

The diagnostic performance of models selected by ANN and logistic regression was similar. The analytic methods were found to be roughly equivalent in terms of predictive ability when a small number of variables were chosen. The robust ANN methodology uses a sophisticated nonlinear model, while logistic regression analysis provides insightful information to enhance the interpretation of the model features.

Section snippets

Malignant and Benign Lesion Database

The database analyzed in this study included 43 malignant and 28 benign lesions, the same database as reported in a previous study (18). The 43 patients with malignant lesions were aged 29 to 76 years (mean ± standard deviation, 48 ± 9 years; median, 48 years). The 28 patients with benign lesions were aged 21 to 74 years (mean, 45 ± 7 years; median, 45 years). The MRI studies were performed using a Philips Eclipse 1.5-T scanner (Philips, Cleveland, OH). The images were acquired using a

ANN Diagnostic Feature Selection and Evaluation

Before ANN training, features were transformed to z scores on the basis of the mean and SD of the entire set of 71 lesions. A three-layer ANN with 5 hidden nodes in the hidden layer was chosen after a number of trial-and-error runs. The diagnostic measures used to assess differentiation between 43 malignant and 28 benign lesions are summarized in Table 1. Considering the eight morphology features, the classifier selected by ANN included three parameters: lesion volume, NRL entropy, and

Discussion

The primary aim of this study was to compare ANN and logistic regression analysis for lesion classification to differentiate between malignant and benign breast lesions in patients. Using our data set of 71 lesions, the ANN procedure was applied to select the best classifiers for morphologic and texture (GLCM and Laws) category features. The three selected morphologic features (volume, NRL entropy, and compactness) achieved a moderate AUC of 0.80 and estimated accuracy of 0.77. The three

References (40)

  • G.P. Liney et al.

    Breast lesion analysis of shape technique: semiautomated vs. manual morphological description

    J Magn Reson Imaging

    (2006)
  • L.A. Meinel et al.

    Breast MRI lesion classification: improved performance of human readers with a backpropagation neural network computer-aided diagnosis (CAD) system

    J Magn Reson Imaging

    (2007)
  • L. Esserman et al.

    Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging

    J Clin Oncol

    (1999)
  • U. Fischer et al.

    Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach

    Radiology

    (1999)
  • H. Mumtaz et al.

    Staging of symptomatic primary breast cancer with MR imaging

    AJR Am J Roentgenol

    (1997)
  • A. Rieber et al.

    Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk?

    Br J Radiol

    (2002)
  • Y. Zhang et al.

    The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery

    Breast Cancer

    (2002)
  • K.G. Gilhuijs et al.

    Computerized analysis of breast lesions in three dimensions using dynamic magnetic-resonance imaging

    Med Phys

    (1998)
  • H.P. Chan et al.

    Computerized classification of malignant and benign microcalcifications on mammograms: texture analysis using an artificial neural network

    Phys Med Biol

    (1997)
  • D.J. Sargent

    Comparison of artificial neural networks with other statistical approaches

    Cancer

    (2001)
  • Cited by (75)

    • Performance of Machine Learning Methods Based on Multi-Sequence Textural Parameters Using Magnetic Resonance Imaging and Clinical Information to Differentiate Malignant and Benign Soft Tissue Tumors

      2023, Academic Radiology
      Citation Excerpt :

      Image texture refers to a set of metrics for digital images calculated by mathematical analysis. Many studies have reported that textural analysis by imaging offers highly accurate diagnostic performance for tumors in the brain (10-12), kidney (13), liver (14), prostate (15,16), breast (17), and uterus (18). Many machine learning methods have been applied to image texture analysis (ITA) for diagnosing these tumors.

    • Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features

      2019, Academic Radiology
      Citation Excerpt :

      Many studies have reported that image texture analysis offers high diagnostic performance for tumors in the brain (7–9), soft tissue (10), kidney (11), liver (12), prostate (13,14), and breast (15), and a recent preliminary study suggested that texture analysis could also be used to differentiate uterine leiomyosarcoma from atypical leiomyoma (16). Various machine learning methods and algorithms have been used for these analyses, including logistic regression (14), support vector machines (7,10,17), multilayer perceptron artificial neural networks (10,15), and the k-nearest neighbors (8,12), naive Bayes (18), and random forest algorithms (9,13). Recently, a new machine learning method called eXtreme Gradient Boosting (XGBoost) was introduced by Chen and Guestrin (19), although it has not yet been used extensively for medical image analysis.

    • NCTN Assessment on Current Applications of Radiomics in Oncology

      2019, International Journal of Radiation Oncology Biology Physics
    • Decision support systems in breast cancer

      2019, Precision Medicine for Investigators, Practitioners and Providers
    View all citing articles on Scopus

    This work was supported in part by grant R01 CA90437 (O. Nalcioglu) and R21 CA121568 (M.-Y.Su) from the National Cancer Institute (Bethesda, MD), grants 9WB-0020 (M.-Y. Su) and 14GB-0148 (K. Nie) from the California Breast Cancer Research Program (Oakland, CA), and Cancer Center Support Grant No. 2P30CA062203-13S (F.L. Meyskens, Jr) from the National Cancer Institute (Bethesda, MD).

    View full text